MYNZ (MYNZ)
Mainz Biomed B.V.
NASDAQ:MYNZHealthcare · Medical - Diagnostics & Research
Mkt Cap-
Float7.92M
O/S-
Inst Own-
Dilution
Delisting Issues Timeline
Financials Summary
Revenue$537K
Net Income-$16.21M
Total Assets$5.33M
Free Cash Flow-$10.98M
Debt & Equity
Debt 80%
Equity 20%
Total Debt$2.57M
Total Equity$642K
Shares Outstanding
Short Interest
Split History1 split · 1 reverse
2-year cumulative
1:40
Nasdaq bars a compliance period at 1:250
- 1:40Reverse splitDec 3, 202440 shares → 1
Balance Sheet Details
Assets$5.33M
Liabilities$4.69M
Accounts Receivable$111K
Accounts Payable$425K
Inventory$217K
PP&E (Net)$2.37M
Goodwill$0
Intangible Assets$1.11M
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Revenue | $537K | $894K | $895K | $530K | $577K | $494K | $281K |
| YoY Growth | -39.9% | -0.2% | 69.0% | -8.2% | 17.0% | 75.4% | - |
| Cost of Revenue | $763K | $319K | $386K | $348K | $400K | $370K | $343K |
| Gross Profit | -$226K | $575K | $510K | $182K | $178K | $123K | -$61K |
| Gross Margin | -42.1% | 64.3% | 56.9% | 34.4% | 30.8% | 24.9% | -21.8% |
| Research and Development | $4.91M | $5.84M | $9.59M | $3.66M | $467K | $312K | $250K |
| Selling, General, and Administrative | $8.93M | $12.77M | $17.22M | $22.81M | $9.41M | $458K | $570K |
| Other | -$561K | $656K | $342K | -$114K | -$321K | $27K | -$130K |
| Total Operating Expenses | $13.27M | $19.27M | $27.15M | $26.36M | $9.56M | $797K | $690K |
| Operating Income (EBIT) | -$13.5M | -$18.7M | -$26.64M | -$26.44M | -$9.72M | -$766K | -$922K |
| Operating Margin | -2513.4% | -2091.2% | -2975.5% | -4990.6% | -1684.4% | -155.2% | -327.6% |
| Interest Expense | -$373K | $1.08M | $810K | $289K | $339K | $269K | $202K |
| Interest Income | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Income (Expense) | -$2.71M | -$2.96M | $349K | $57K | -$1.97M | $87K | -$35K |
| Income Before Tax (EBT) | -$16.21M | -$21.65M | -$26.3M | -$26.39M | -$11.7M | -$587K | -$957K |
| Income Tax Expense | $0 | $0 | $0 | $0 | $377K | $0 | $0 |
| Net Income | -$16.21M | -$21.65M | -$26.3M | -$26.45M | -$11.69M | -$587K | -$957K |
| Net Income Margin | -3018.3% | -2421.8% | -2936.5% | -4992.2% | -2024.8% | -118.9% | -340.1% |
| Supplementary Data | |||||||
| EPS | -2.70 | -22.36 | -1.62 | -1.87 | -1.67 | -0.05 | -0.10 |
| Diluted EPS | -2.70 | -22.36 | -1.62 | -1.87 | -1.67 | -0.05 | -0.10 |
| Weighted Average OS | 6.00M | 968,234 | 16.24M | 14.16M | 7.21M | 5.61M | 11.71M |
| EBITDA | -$12.88M | -$19.56M | -$25.18M | -$25.72M | -$11.28M | -$350K | -$702K |
| EBITDA Margin | -2398.7% | -2187.8% | -2811.8% | -4853.6% | -1953.9% | -70.9% | -249.5% |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Assets | |||||||
| Current Assets | |||||||
| Cash and Cash Equivalents | $889K | $6.24M | $7.07M | $17.14M | $8.73M | $123K | $204K |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $889K | $6.24M | $7.07M | $17.14M | $8.73M | $123K | $204K |
| Accounts Receivable | $111K | $214K | $355K | $259K | $18K | $44K | $41K |
| Inventory | $217K | $373K | $614K | $175K | $0 | $0 | $0 |
| Other Current Assets | $0 | $127K | $135K | $0 | $0 | $0 | $0 |
| Total Current Assets | $1.84M | $7.84M | $8.98M | $18.38M | $9.61M | $186K | $260K |
| Long-Term Assets | |||||||
| Property, Plant & Equipment Net | $2.37M | $2.38M | $3.03M | $1.84M | $432K | $487K | $456K |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $1.11M | $3.02M | $3.39M | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $0 | $0 | $108 | $23K | $0 | $0 | $0 |
| Total Long-Term Assets | $3.49M | $5.39M | $6.43M | $1.86M | $432K | $487K | $456K |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $5.33M | $13.24M | $15.41M | $20.24M | $10.04M | $673K | $716K |
| Liabilities | |||||||
| Current Liabilities | |||||||
| Accounts Payable | $425K | $1.25M | $2.33M | $1.33M | $833K | $195K | $200K |
| Short-Term Debt | $1.22M | $2.13M | $4.94M | $1.04M | $193K | $219K | $174K |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $3K | $20K | $5K |
| Current Unearned Revenue | $0 | $0 | $139K | $199K | $0 | $2K | $3K |
| Other Current Liabilities | $1.16M | $691K | $389K | $2.28M | -$3K | $98K | $0 |
| Total Current Liabilities | $3.69M | $5.95M | $9.24M | $4.24M | $1.35M | $702K | $460K |
| Long-Term Liabilities | |||||||
| Long-Term Debt | $0 | $0 | $1.03M | $943K | $1.94M | $2.27M | $1.79M |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $0 | $376K | $727K | $0 | $0 | $0 | $0 |
| Total Long-Term Liabilities | $992K | $1.24M | $2.92M | $1.9M | $2.33M | $2.71M | $2.21M |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $4.69M | $7.19M | $12.16M | $6.14M | $3.68M | $3.41M | $2.67M |
| Stockholders' Equity | |||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Common Stock | $108K | $922K | $236K | $165K | $141K | $64K | $106K |
| Retained Earnings | -$104.9M | -$90.98M | -$69.33M | -$43.03M | -$16.64M | -$4.95M | -$4.37M |
| Comprehensive Income & Other | -$618K | $27.04M | $20.83M | $18.13M | $9.74M | $2.11M | $2.31M |
| Other Stockholders' Equity | $105.44M | $96.1M | $72.34M | $56.96M | $22.87M | $2.15M | $2.31M |
| Total Equity | $642K | $6.05M | $3.25M | $14.1M | $6.36M | -$2.74M | -$1.95M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $5.33M | $13.24M | $15.41M | $20.24M | $10.04M | $673K | $716K |
| Supplementary Data | |||||||
| Total Debt | $2.57M | $3.27M | $7.42M | $3.23M | $2.58M | $2.98M | $2.41M |
| Net Debt | $1.68M | -$2.96M | $350K | -$13.91M | -$6.15M | $2.86M | $2.21M |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Operating Activities | |||||||
| Net Income | -$16.21M | -$21.65M | -$26.3M | -$26.39M | -$11.69M | -$587K | -$957K |
| Depreciation & Amortization | $616K | $1.02M | $866K | $380K | $70K | $60K | $53K |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Stock-Based Compensation | $1.2M | $1.14M | $4.01M | $9.82M | $6.43M | $0 | $0 |
| Changes in Working Capital: | |||||||
| Accounts Receivable | $71K | $64K | $16K | -$211K | $24K | -$99K | $340K |
| Inventory | -$100K | $30K | -$500K | -$172K | -$670.73M | -$160K | $0 |
| Accounts Payable | -$2.07M | $85K | $720K | $0 | $670.73M | $160K | $0 |
| Other Working Capital | $465K | -$127K | -$300K | -$54K | -$163K | $157K | $83K |
| Total Working Capital Change | -$1.63M | $52K | -$65K | -$437K | -$139K | $58K | $423K |
| Other Non-Cash Items | $5.05M | $2.36M | -$451K | $1.85M | $2.11M | $107 | $64K |
| Net Cash from Operating | -$10.98M | -$17.09M | -$21.94M | -$14.77M | -$3.22M | -$469K | -$416K |
| Investing Activities | |||||||
| Capital Expenditures | -$1K | -$105K | -$1.2M | -$658K | -$17K | -$10K | $0 |
| Acquisitions | $0 | $33K | $0 | $0 | $1.22M | $0 | $0 |
| Purchases of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Sales of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Investing Activities | -$1.03M | -$127K | -$700K | $0 | $0 | $0 | $0 |
| Net Cash from Investing | -$1.03M | -$199K | -$1.9M | -$658K | $1.2M | -$10K | $0 |
| Financing Activities | |||||||
| Debt Repaid | $242K | $295K | $1.19M | $198K | -$178K | $39K | -$420K |
| Common Stock Issuance | $8.25M | $13.76M | $6.39M | $24.25M | $10.43M | $0 | $0 |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | -$243K | $0 | $0 | -$107K | $0 | $399K | $0 |
| Net Cash from Financing | $6.76M | $16.6M | $14.23M | $23.94M | $10.61M | $397K | $424K |
| Forex Effect | -$97K | -$146K | -$460K | -$101K | $12K | $721 | -$33K |
| Net Change in Cash | -$5.35M | -$835K | -$10.07M | $8.41M | $8.6M | -$81K | -$26K |
| Supplementary Data | |||||||
| Operating Cash Flow | -$10.98M | -$17.09M | -$21.94M | -$14.77M | -$3.22M | -$469K | -$416K |
| Capital Expenditure | -$1K | -$255K | -$1.9M | -$658K | -$17K | -$10K | $0 |
| Free Cash Flow | -$10.98M | -$17.34M | -$23.84M | -$15.43M | -$3.24M | -$478K | -$416K |
| Cash at Beginning | $6.24M | $7.07M | $17.14M | $8.73M | $123K | $204K | $230K |
| Cash at End | $889K | $6.24M | $7.07M | $17.14M | $8.73M | $123K | $204K |